Get started
Author

Chinami Masuda

Observed names: C. Masuda, MASUDA, CHINAMI
ORCID: 0000-0002-8945-2569
Observed ORCID: 0000-0002-8945-2569
OpenAlex ID: A5040972707
Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model
2017 · Chinami Masuda, Mieko Yanagisawa, et al. · International Journal of Oncology · 83
PDF
Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model
2019 · Chinami Masuda, Masamichi Sugimoto, et al. · Clinical & Experimental Metastasis · 37
PDF
MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells
2017 · Masanobu Nishidate, Kaname Yamamoto, et al. · Scientific Reports · 17
PDF
PD-L1 and VEGF dual blockade enhances anti-tumor effect on brain metastasis in hematogenous metastasis model
2024 · Chinami Masuda, Shinichi Onishi, et al. · Clinical & Experimental Metastasis · 5
PDF
PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8+ T cells in hematogenous metastasis model with lymphocyte infusion
2021 · Chinami Masuda, Mamiko Morinaga, et al. · Clinical & Experimental Metastasis · 3
PDF
644 Antitumor mechanism of anti-PD-L1+anti-TIGIT combination therapy mediated by immune cells other than CD8+ T cells in mouse tumor models
2025 · Mamiko Morinaga, Chinami Masuda, et al. · Regular and Young Investigator Award Abstracts
PDF
マウスモデルを用いたがんの再発転移抑制に関する研究
2023 · MASUDA, CHINAMI · Institutional Repositories DataBase (IRDB)
P2.02-051 Bevacizumab Prevents Growth of Established Non-Small Cell Lung Cancer Brain Metastases in Hematogenous Brain Metastasis Model
2017 · C. Masuda, M. Monnai, et al. · Journal of Thoracic Oncology
Works count: 8
Citation count: 145
H-index: 4
I10-index: 3
Year
Topic
Type